Effect of drug treatments during repeated withdrawals on the reduction in social interaction induced by restraint stress. The 5-HT1A agonist, buspirone, (Busp; 0.6 mg/kg), flumazenil (Flumaz; 5 mg/kg), a benzodiazepine antagonist, or the CRF1-receptor antagonist, CP154,526 (10 mg/kg), were administered during the first two withdrawal periods, but not the final withdrawal, of the multiple-withdrawal protocol. Vehicle was given to the group that received ethanol diet and stress (ET Diet Stress Veh). All drug treatments significantly prevented the reduction in social interaction induced by stress applied 3 days following the repeated withdrawals. *p < 0.05 (F(6,48) = 2.77) compared to Ethanol Diet No Stress, Control Diet Stress, and Control Diet No stress groups and all drug groups stressed (Ethanol Diet Stress—buspirone (Busp), flumazenil (Flumaz), and CP-154,526 groups). Locomotor activity was not reduced following stress in any of the drug treatment groups compared to Ethanol No Stress (F(6,48) = 2.00; p > 0.05).